Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis
Science Advances · 2023
DOI: 10.1126/sciadv.ade3422 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2023. Verfasst von Pei-Ling Hsu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anatomy, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Matrix Metalloproteinase 2. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Metastasis is the main cause of death in many cancers including colorectal cancer (CRC); however, the underlying mechanisms responsible for metastatic progression remain largely unknown. We found that nuclear TYRO3 receptor tyrosine kinase is a strong predictor of poor overall survival in patients with CRC. The metastasis-promoting function of nuclear TYRO3 requires its kinase activity and matrix metalloproteinase–2 (MMP-2)–mediated cleavage but is independent of ligand binding. Using proteomic analysis, we identified bromodomain-containing protein 3 (BRD3), an acetyl-lysine reading epigenetic regulator, as one of nuclear TYRO3’s substrates. Chromatin immunoprecipitation-sequencing data reveal that TYRO3-phosphorylated BRD3 regulates genes involved in anti-apoptosis and epithelial-mesenchymal transition. Inhibition of MMP-2 or BRD3 activity by selective inhibitors abrogates nuclear TYRO3-induced drug resistance and metastasis in organoid culture and in orthotopic mouse models. These data demonstrate that MMP-2/TYRO3/BRD3 axis promotes the metastasis of CRC, and blocking this signaling cascade is a promising approach to ameliorate CRC malignancy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Anatomy, School of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
- Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung 80708, Taiwan.
- Department of Physiology, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
- Institute of Molecular Medicine, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
- Division of Colorectal Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
- Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
ORCID-Profile: Pei-Ling Hsu, Yen-An Tang, Shih-Chieh Lin, Yi-Syuan Lin, H Sunny Sun, Shaw-Jenq Tsai
Zitieren
APA
Hsu, P. L., Chien, C. W., Tang, Y. A., Lin, B. W., Lin, S. C., Lin, Y. S., Chen, S. Y., Sun, H. S., & Tsai, S. J. (2023). Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis. Science Advances. https://doi.org/10.1126/sciadv.ade3422
Vancouver
Hsu PL, Chien CW, Tang YA, Lin BW, Lin SC, Lin YS, et al. Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis. Science Advances. 2023. doi:10.1126/sciadv.ade3422
BibTeX
@article{Hsu2023,
author = {Hsu, Pei-Ling and Chien, Chun-Wei and Tang, Yen-An and Lin, Bo-Wen and Lin, Shih-Chieh and Lin, Yi-Syuan and Chen, Sih-Yu and Sun, H Sunny and Tsai, Shaw-Jenq},
title = {Targeting BRD3 eradicates nuclear TYRO3-induced colorectal cancer metastasis},
journal = {Science Advances},
year = {2023},
doi = {10.1126/sciadv.ade3422}
}
EUVIMED